Adili Tsaba
Direttore Tecnico/Scientifico/R&S presso VESSL Therapeutics Ltd.
Posizioni attive di Adili Tsaba
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
VESSL Therapeutics Ltd.
 VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Direttore Tecnico/Scientifico/R&S | 01/01/2001 | - |
| Consigliere Generale | 01/01/2001 | - |
Storia della carriera di Adili Tsaba
Formazione di Adili Tsaba
| Technion-Israel Institute of Technology | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Israele | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| General Counsel | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |
- Borsa valori
- Insiders
- Adili Tsaba
- Esperienza
